Literature DB >> 7231681

Evolution of brain abscess in cats formation of capsule and resolution of brain edema.

T Wallenfang, J Bohl, K Kretzschmar.   

Abstract

Brain abscess evolution was studied in an experimental model in the cat correlating the computed tomographic scan appearance with intracranial pressure, brain edema and histopathological findings. Brain inflammation was produced by direct inoculation of Staphylococcus aureus into the white matter. Abscesses developed in all animals. The ring enhancement around the necrotic focus seen at an early stage after contrast-medium injection cannot be equated with capsule formation as long as the abscess diameter increased. Parallel to the acute stage of abscess, the intraventricular pressure increased due to the rising mass effect and the spreading edma. The morphological investigations revealed on the seventh day an extreme enlargement of extracellular spaces with immense amount of edema fluid, rich in protein and fibrin. Some blood vessels in the close vicinity of the abscess showed gaps within the endothelial cell layer. When encapsulation developed, ring enhancement became more homogeneous and decreased in diameter. In spite of encapsulation, a circumscribed disturbance of the blood-brain barrier persisted which was responsible for a belated resolution of edema and a slow decrease of intracranial pressure. Only therapy with dexamethasone could effect a marked change in the course of the disease.

Entities:  

Mesh:

Year:  1980        PMID: 7231681     DOI: 10.1007/bf01644062

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  10 in total

1.  Decadron in the treatment of cerebral abscess. An experimental study.

Authors:  G R Quartey; J A Johnston; B Rozdilsky
Journal:  J Neurosurg       Date:  1976-09       Impact factor: 5.115

2.  Surgical treatment of brain abscess and subdural empyema.

Authors:  J Le Beau; P Creissard; L Harispe; A Redondo
Journal:  J Neurosurg       Date:  1973-02       Impact factor: 5.115

3.  Long-term neurological residua in patients surviving brain abscess with surgery.

Authors:  M E Carey; S N Chou; L A French
Journal:  J Neurosurg       Date:  1971-05       Impact factor: 5.115

4.  Management of supratentorial intracranial abscess: a review of 200 cases.

Authors:  J Garfield
Journal:  Br Med J       Date:  1969-04-05

5.  Steroids and cerebral edema: the effects of glucocorticoids on abnormal capillary permeability following cerebral injury in cats.

Authors:  R L Rovit; R Hagan
Journal:  J Neuropathol Exp Neurol       Date:  1968-04       Impact factor: 3.685

Review 6.  Presidental address. Neuropathological aspects of brain edema.

Authors:  I Klatzo
Journal:  J Neuropathol Exp Neurol       Date:  1967-01       Impact factor: 3.685

7.  Evolution of cerebral abscess: correlation of clinical features with computed tomography. A case report.

Authors:  R A Zimmerman; L T Bilaniuk; P M Shipkin; D H Gilden; F Murtagh
Journal:  Neurology       Date:  1977-01       Impact factor: 9.910

8.  The effects of glucosteroids on experimental cold-induced brain edema. Gross morphological alterations and vascular permeability changes.

Authors:  R E Maxwell; D M Long; L A French
Journal:  J Neurosurg       Date:  1971-04       Impact factor: 5.115

9.  Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema.

Authors:  H J Reulen; R Graham; M Spatz; I Klatzo
Journal:  J Neurosurg       Date:  1977-01       Impact factor: 5.115

10.  Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema.

Authors:  H J Reulen; M Tsuyumu; A Tack; A R Fenske; G R Prioleau
Journal:  J Neurosurg       Date:  1978-05       Impact factor: 5.115

  10 in total
  11 in total

1.  Effect of dexamethasone on various stages of experimental brain abscess.

Authors:  A Yildizhan; A Paşaoğlu; B Kandemir
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

2.  Advantage of magnetic resonance imaging in the diagnosis of cerebral infections.

Authors:  G Schroth; K Kretzschmar; J Gawehn; K Voigt
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

3.  Treatment of experimental brain abscess. 2. Effects of combinations of hyaluronidase with antibiotics and dexamethasone.

Authors:  A Paşaoğlu; A Yildizhan; B Kandemir
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

4.  CT-guided stereotactic aspiration and treatment of brain abscesses. An experience with 24 cases.

Authors:  M G Hasdemir; U Ebeling
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

5.  Short term, high dose corticosteroids in computed tomographic staging of experimental brain abscess.

Authors:  B E Lyons; D R Enzmann; R H Britt; W G Obana; R C Placone; A S Yeager
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

6.  CT studies of brain abscesses in cats.

Authors:  K Kretzschmar; T Wallenfang; J Bohl
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

7.  Propofol Sedation Exacerbates Kidney Pathology and Dissemination of Bacteria during Staphylococcus aureus Bloodstream Infections.

Authors:  Lavanya Visvabharathy; Nancy E Freitag
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Development and characterization of an experimental model of brain abscess in the rat.

Authors:  N A Flaris; W F Hickey
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

9.  Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues.

Authors:  Alice G Cheng; Hwan Keun Kim; Monica L Burts; Thomas Krausz; Olaf Schneewind; Dominique M Missiakas
Journal:  FASEB J       Date:  2009-06-12       Impact factor: 5.191

10.  Persistence and progression of staphylococcal infection in the presence of public goods.

Authors:  Urvish Trivedi; Cody Fell; Jonas S Madsen; Jake Everett; Mette Burmølle; Kendra P Rumbaugh; Søren J Sørensen
Journal:  NPJ Biofilms Microbiomes       Date:  2020-11-27       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.